Targeting mitochondrial metabolism to overcome hormone resistance in breast cancer.
1/5 보강
Breast cancer remains a leading cause of cancer-related morbidity in women worldwide, with hormone receptor-positive (HR +) subtypes comprising approximately 70% of cases.
APA
Neamah AS, Lafta FM, Wadan AS (2026). Targeting mitochondrial metabolism to overcome hormone resistance in breast cancer.. Naunyn-Schmiedeberg's archives of pharmacology, 399(2), 1639-1655. https://doi.org/10.1007/s00210-025-04487-z
MLA
Neamah AS, et al.. "Targeting mitochondrial metabolism to overcome hormone resistance in breast cancer.." Naunyn-Schmiedeberg's archives of pharmacology, vol. 399, no. 2, 2026, pp. 1639-1655.
PMID
40833601 ↗
Abstract 한글 요약
Breast cancer remains a leading cause of cancer-related morbidity in women worldwide, with hormone receptor-positive (HR +) subtypes comprising approximately 70% of cases. Despite advances in endocrine therapies, the development of hormone resistance poses a major challenge, often leading to treatment failure and disease progression. This review addresses the central problem of resistance in HR + breast cancer (HR + BC), focusing on key mechanisms such as mutations in the estrogen receptor (ER), activation of alternative survival pathways including the PI3K/Akt/mTOR axis, and the inherent heterogeneity of tumors. Emerging therapies aim to overcome these barriers by combining hormone treatments with targeted inhibitors. Special emphasis is placed on novel approaches involving mitochondrial disruption, epigenetic modulation, and manipulation of the tumor microenvironment. These strategies reflect a shift toward personalized medicine, where molecular profiling and biomarker identification guide individualized treatment plans. Understanding and targeting the multifactorial nature of resistance in HR + BC is essential to improving therapeutic outcomes. A multidisciplinary, mechanism-based approach offers the most promise for restoring treatment sensitivity and enhancing long-term survival.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.